TSXV:KHRN.H (Khiron Life Sciences)

Khiron Life Sciences Corp. is a vertically integrated medical and consumer packaged goods (CPG) cannabis company with core operations in Latin America and operational activities in Europe and North America. It provides medical cannabis in Colombia and focuses on the cultivation, production, international export, domestic distribution and sale of THC (tetrahydrocannabinol) medical cannabis products. The firm operates through the following segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The Medical Cannabis Products segment involves in growth, production and sale of branded products and services to patients with medical conditions where cannabis can be an acceptable, proven option. The Health Services segment operates its medium complexity health centers offering a suite of health, medical and surgical services in alignment with insurance company partners. The Wellbeing Products segment focuses on delivering the benefits of CBD and hemp across an array of various branded consumer packaged goods, such as Kuida cosmetics line. The company was founded by Álvaro F. Torres on May 16, 2012 and is headquartered in Vancouver, Canada.